Home Products PNExo™ Exosome-Turmeric
PNExo™ Exosome-Turmeric
Product Image

PNExo™ Exosome-Turmeric

Catalog No. PNE-HTU78

Price (USD)

$1,190.00
Order Request a Bulk Order
Request a Quote Download Datasheet

Product Summary

Source
Turmeric
Product Overview
PNExo™ Exosome Series (Exosomes isolated from Herbages) are nanosized (30-150 nm) membrane vesicles extracted from a diverse range of herbaceous plants, rich in bioactive molecules and proteins. These naturally derived nanoparticles contain a variety of bioactive molecules and proteins, which have been proven to offer numerous benefits in skincare, drug delivery, and biomedicine. Herbage exosomes, with their antioxidant, anti-inflammatory, and anti-aging properties, have become an attractive option for the development of innovative therapies. PNExo™ is dedicated to the production and delivery of high-quality herbage-derived exosome products. Our products undergo a rigorous screening and purification process to ensure their high purity and activity. We can provide both lyophilized powder and frozen liquid according to customer requirements. Lyophilized powder is beneficial for long-term storage at 4°C, while frozen liquid should be maintained at temperatures between -20°C and -80°C. Ultracentrifugation, PEG precipitation, and Tangential Flow Filtration (TFF) technology are utilized for the isolation and production of exosomes, ensuring the highest quality and purity. Creative Biostructure PNExo™ exosome products guarantee higher purity and quality, and we can provide exosome GMP production and CDMO services to meet our customers' research and production needs.
Form
Lyophilized powder / Frozen Liquid
Concentration
> 1x10^10 particles
Storage
Lyophilized powder store at 4 °C. Frozen liquid store at -20°C to -80°C. Recommended to avoid repeated freeze-and-thaw cycles.
Reconstitution
Reconstitute lyophilized exosome by adding deionized water for a desired final concentration. Centrifuge before opening to ensure exosomes are at bottom, resuspend exosomes by pipetting and/or vortex, please avoid bubbles. Centrifuge again and mix well for using.
Efficacy
Antioxidant, Anti-inflammatory, Anti-cancer

Scientific Background

Active Components and Actions of Turmeric

Turmeric (Curcuma longa) is a well-studied herbaceous plant recognized for its broad spectrum of biological activities. These effects are primarily attributed to a unique combination of bioactive compounds that act synergistically.

  • Curcumin (70-75% of total curcuminoids): The most abundant and well-researched compound, curcumin exhibits strong anti-inflammatory activity by inhibiting critical signaling pathways such as NF-κB, COX-2, and IL-6, leading to reduced pro-inflammatory mediator production. It also acts as a potent antioxidant, neutralizing free radicals and activating the Nrf2 pathway to enhance endogenous antioxidant enzymes like superoxide dismutase (SOD). In vitro studies have also shown curcumin's ability to induce apoptosis in tumor cells, suppress STAT3 and MAPK pathways, and inhibit angiogenesis, suggesting a role in cell proliferation regulation.
  • Demethoxycurcumin (10-25%): Shares similar anti-inflammatory properties and contributes to the regulation of cell growth and signaling pathways.
  • Bisdemethoxycurcumin (5-10%): Primarily exhibits antioxidant activity and has been investigated for its role in modulating cell migration and oxidative stress responses.
  • Volatile oils (e.g., α-turmerone, β-turmerone): These compounds are thought to possess antimicrobial properties and support the actions of curcuminoids.
  • Phenolic compounds: These secondary metabolites may contribute to metabolic regulation and cellular signaling.

What are Turmeric-derived Exosomes?

The term Turmeric Exosomes generally refers to two distinct forms. Firstly, there are naturally derived exosomes extracted directly from Curcuma longa (turmeric) plant cells. These plant-derived nanovesicles may naturally carry various plant metabolites, including, but not limited to, curcuminoids, along with plant-specific RNAs and lipids. Secondly, the term can also refer to curcumin-loaded exosomes. These are composite nanoparticles created by encapsulating curcumin, the primary active compound of turmeric, within exosomes sourced from other origins, such as milk or mammalian cells. This engineered approach aims to enhance the stability and bioavailability of curcumin by leveraging the natural delivery capabilities of exosomes. These artificially loaded exosomes are typically within the 30-150 nm size range and are formed by methods like co-incubation or electroporation, resulting in a core exosomal membrane structure (often identifiable by markers like CD63 and CD81) encapsulating curcumin, with reported drug loading capacities.

Turmeric-derived exosomes exhibit teacup-shaped morphology, rich in lipids, proteins, and curcumin-related small molecules from turmeric.Characterization of Turmeric-Derived Exosome-Like Nanoparticles (TELNs) (Wei Y, et al., 2023)

Potential Applications of Turmeric-Derived Exosomes

Turmeric-derived exosomes, combining the natural bioactivity of turmeric with the intrinsic advantages of nanoscale vesicles, are gaining increasing attention across multiple biomedical research areas. Their ability to act as natural nanocarriers, coupled with a favorable safety profile, positions them as valuable tools in preclinical studies.

  • Turmeric Exosomes in Cancer Biology Research

    Recent studies have explored turmeric exosomes as potential vehicles for the targeted delivery of bioactive compounds to tumor sites. Evidence suggests they may inhibit key oncogenic signaling pathways, including STAT3 and NF-κB, thereby enhancing pro-apoptotic signaling. For example, in a CaSki cervical cancer mouse model, curcumin-loaded turmeric exosomes demonstrated a 61% reduction in tumor volume, significantly outperforming orally administered curcumin.

  • Anti-inflammatory Potential of Turmeric Exosomes

    Turmeric exosomes are being studied for their role in modulating inflammatory responses. They have been observed to suppress NLRP3 inflammasome activation and reduce the release of interleukin-1β (IL-1β) in cell-based models. This anti-inflammatory activity may have implications for the study of conditions such as rheumatoid arthritis and inflammatory bowel disease, where chronic inflammation plays a central role.

  • Neuroprotective Applications

    Plant-derived exosomes, including those from turmeric, have demonstrated the potential to cross the blood-brain barrier (BBB), making them suitable candidates for delivering bioactive molecules to the central nervous system. Preclinical research is investigating their use in neurodegenerative disease models, including Alzheimer's disease, where they may help reduce β-amyloid accumulation and improve cognitive function through enhanced curcumin delivery.

  • Skin Health and Anti-aging Effects of Turmeric Exosomes

    Turmeric exosomes, when combined with curcumin, have shown promising results in promoting skin rejuvenation. Studies indicate they can stimulate type I collagen synthesis and suppress UV-induced MMP-1 expression, both key factors in skin aging. In 3D-cultured human dermal fibroblast models, the combination significantly enhanced collagen deposition, suggesting potential applications in anti-aging skincare formulations.

  • Enhancing Skin Barrier Function

    Research has identified turmeric-derived exosomes as potential modulators of epidermal differentiation proteins, including filaggrin, which are crucial for maintaining skin integrity. This may support future investigations into their use in conditions like eczema and psoriasis, where skin barrier dysfunction is a hallmark.

  • Turmeric Exosomes in Wound Healing Studies

    The regenerative potential of turmeric exosomes is being examined for their ability to promote angiogenesis and epithelial repair. When combined with curcumin, they may synergistically accelerate wound closure by modulating miRNA expression involved in tissue regeneration.

References

  1. Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Molecular Therapy. 2010, 18(9): 1606-1614. https://doi.org/10.1038/mt.2010.105
  2. Aqil F, Munagala R, Jeyabalan J, et al. Exosomes for the enhanced tissue bioavailability and efficacy of curcumin. The AAPS Journal. 2017, 19: 1691-1702. https://doi.org/10.1208/s12248-017-0154-9
  3. Vashisht M, Rani P, Onteru S K, et al. Curcumin encapsulated in milk exosomes resists human digestion and possesses enhanced intestinal permeability in vitro. Applied Biochemistry and Biotechnology. 2017, 183: 993-1007. https://doi.org/10.1007/s12010-017-2478-4
  4. Oskouie M N, Aghili Moghaddam N S, Butler A E, et al. Therapeutic use of curcumin‐encapsulated and curcumin‐primed exosomes. Journal of Cellular Physiology. 2019, 234(6): 8182-8191. https://doi.org/10.1002/jcp.27615
  5. Panzarini E, Mariano S, Tacconi S, et al. Novel therapeutic delivery of nanocurcumin in central nervous system related disorders. Nanomaterials. 2020, 11(1): 2. https://doi.org/10.3390/nano11010002
  6. Jyotirmayee B, Mahalik G. A review on selected pharmacological activities of Curcuma longa L. International Journal of Food Properties. 2022, 25(1): 1377-1398. https://doi.org/10.1080/10942912.2022.2082464
  7. Gao C, Zhou Y, Chen Z, et al. Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis. Theranostics. 2022, 12(12): 5596. https://doi.org/10.7150/thno.73650
  8. Wei Y, Cai X, Wu Q, et al. Extraction, isolation, and component analysis of turmeric-derived exosome-like nanoparticles. Bioengineering. 2023, 10(10): 1199. https://doi.org/10.3390/bioengineering10101199

Case Study

Case Study 1: Case Study: Exosomal Delivery Boosts Curcumin Performance (Sun D, 2010)

A study showed that curcumin loaded into exosomes becomes 5× more soluble and remains over 80% stable after 150 minutes at 37 °C, compared to just 25% for free curcumin. In vivo, plasma levels of curcumin were 5-10× higher after exosomal delivery, with sustained circulation up to 12 hours. In an LPS-induced inflammation model, exosomal curcumin significantly reduced IL-6 and TNF-α levels and improved mouse survival, outperforming both free and liposomal curcumin. These findings support the use of exosomes as a natural, targeted delivery system to enhance curcumin’s bioactivity.

Exosomal encapsulation improves curcumin solubility and stability in PBS compared to free curcumin.Figure 1. Encapsulation of Curcumin in Exosomes Enhances Its Solubility and Stability In Vitro. (a) Curcumin encapsulated in exosomes shows higher solubility in phosphate-buffered saline (PBS) than free curcumin, as measured by OD420 spectrophotometry. (b) Exosomal curcumin maintains greater stability over time in PBS at 37 °C, compared to free curcumin. Concentrations were normalized to baseline (1.00); data represent mean ± SD, *p < 0.05, **p < 0.01.
Exosomal curcumin reduces mortality and cytokine levels in LPS-induced septic shock mouse model.Figure 2. Exosomal Curcumin Protects Against LPS-Induced Septic Shock in Mice. (a) C57BL/6J mice co-injected intraperitoneally with LPS (18.5 mg/kg) and curcumin or exosomal curcumin (4 mg/kg). Exosomal curcumin significantly reduced mortality over 4 days compared to controls (n = 10/group; *p < 0.05, **p < 0.01). (b) Serum IL-6 and TNF-α levels measured 16 hours post-injection show decreased inflammatory cytokine secretion in the exosomal curcumin group (**p < 0.01).

Case Study 2: Turmeric Nanovesicles Support Gut Barrier and Immune Balance (Gao C, 2022)

A study reported that turmeric-derived nanovesicles (TNVs) offer notable benefits in ulcerative colitis research. Orally administered TNVs accumulated selectively at inflamed colon sites and remained stable in simulated gastric and intestinal fluids. In a DSS-induced colitis model, TNVs treatment significantly reduced body weight loss (<5%), preserved colon length (8.2 cm vs. 5.5 cm in untreated mice), and lowered disease activity index scores. At the cellular level, TNVs suppressed key inflammatory cytokines (TNF-α, IL-6, IL-1β) and promoted macrophage polarization toward the M2 phenotype (CD206+ rate increased from 37.8% to 51.4%). TNVs also restored tight junction proteins and reshaped the gut microbiota by increasing beneficial genera such as Lactobacillus and Bifidobacterium. These results highlight TNVs as stable, biocompatible vesicles with potential in intestinal barrier and immune microenvironment modulation.

Distribution of DiR-labeled turmeric-derived nanovesicles (TNVs) in mouse GI tract and colon, with imaging in healthy and DSS-treated mice over time.Figure 1. In Vivo and Ex Vivo Distribution of DiR-Labeled Turmeric-Derived Nanovesicles (TNVs). (A) Whole-body imaging of mice at 2, 6, 12, and 24 h after oral administration of DiR-labeled TNVs from 8–30% and 30–45% sucrose gradient bands. (B–C) Distribution of TNVs in the gastrointestinal tract and distal colon over time. (D) Imaging of healthy, DSS-induced colitis, and TNV-treated mice at 6 h post-administration. (E–F) Quantification of TNV accumulation and radiant efficiency in feces-containing and empty colons. Data shown as mean ± SD, n = 3; *p < 0.05.
Turmeric-derived nanovesicles (TNVs) show cellular uptake, reduce inflammation, and promote M2 polarization in macrophages.Figure 2. Cellular Uptake, Anti-Inflammatory Effects, and Macrophage Polarization Induced by TNVs. (A-B) Fluorescence microscopy images of DiO-labeled TNVs internalized by NCM460 cells and RAW264.7 macrophages after 6 h, with or without inhibitor pretreatment. (C-D) Quantification of TNV uptake by flow cytometry. (E) TNVs reduced TNF-α, IL-6, and MCP-1 secretion in RAW264.7 macrophages, assessed by ELISA. (F-G) Flow cytometry analysis showing increased CD206 expression, indicating M2 macrophage polarization. Data are mean ± SD, n = 3; *p < 0.05.

References

  1. Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Molecular Therapy. 2010, 18(9): 1606-1614. https://doi.org/10.1038/mt.2010.105
  2. Gao C, Zhou Y, Chen Z, et al. Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis. Theranostics. 2022, 12(12): 5596. https://doi.org/10.7150/thno.73650

Frequently Asked Questions

View More FAQs

Downloads

PDF Brochure - Plant-Based Exosomes ↓ PDF Brochure - Harnessing Nature: The Power of Plant-Derived Exosomes ↓ PDF Brochure - Plant-derived Exosome Products ↓ PDF Brochure - Exosomes for Cosmetic Ingredients ↓ PDF Brochure - Exosome Products ↓ PDF Brochure - Exosome Solutions for Your Proceeding Research ↓